All In Biotech

Free tool

FAERS Monitor: Conexxence

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming BLA 761398 or its brand name (Conexxence, Denosumab-Bnht). Reports on generic versions are filed under their own applications.

Reports

16,591

Serious

15,954

96% of reports

Hospitalization

6,861

Death reported

1,936

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • osteonecrosis of jaw1,555
  • diarrhoea1,176
  • fatigue1,137
  • nausea1,087
  • malignant neoplasm progression1,072
  • neutropenia981
  • metastases to bone857
  • off label use845
  • anaemia758
  • vomiting619
  • dyspnoea608
  • hypocalcaemia608
  • decreased appetite606
  • drug ineffective554
  • pyrexia535

Reports by year received

View as table
YearReports
20081
20092
201067
2011136
2012214
2013358
2014474
2015662
2016748
2017636
2018956
20191,013
20201,063
20211,495
20221,772
20231,781
20241,728
20251,748
20261,737

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,037,568 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
osteonecrosis of jawSignal1,55584.980.9120,943
metastases to boneSignal85769.865.355,047
hypocalcaemiaSignal60842.038.823,558
malignant neoplasm progressionSignal1,07213.412.612,219
neutropeniaSignal9819.28.77,162
anaemiaSignal7585.14.72,474
decreased appetiteSignal6063.33.1985
diarrhoeaSignal1,1762.32.2900
pyrexia5352.01.8255
fatigue1,1371.91.8462
nausea1,0871.71.6356
vomiting6191.71.5169
dyspnoea6081.41.360
off label use8451.21.136
drug ineffective5540.50.5242

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.